Skip to content

Physiological Assessment of the Endothelium - Circadian Rhythm and Role of the Sympathetic Nervous System

Studies on the Physiological Meaning of Flow-mediated Constriction, Flow-mediated Dilatation and Vasomotion/Flowmotion: Circadian Variability and Role of the Sympathetic Nervous System.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01713374
Acronym
PAN
Enrollment
40
Registered
2012-10-24
Start date
2012-10-31
Completion date
2014-03-31
Last updated
2015-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endothelial Function

Keywords

endothelial function, sympathetic nervous system

Brief summary

The purpose of this study is to determine whether interventions aimed at increasing sympathetic tone modify endothelial function measures as assessed by the measurement of flow-mediated dilation (FMD) and constriction (FMC). The investigators hypothesize that the three interventions under study will increase FMC while causing a blunting in FMD. Further, the investigators plan to study the circadian variability of FMC and FMD. The investigators hypothesize a peak of FMD in the late hours of the day and a peak of FMC in the early hours.

Interventions

PROCEDUREMental stress

Subjects will be asked to perform complex mathematic operations at a very fast pace

OTHERno intervention

control visit

PROCEDUREMyogenic activation

A pneumatic cuff will be inflated to suprasystolic pressure around both thighs and the subjects will be asked to perform plantar flexion exercises.

A hand will be placed in ice-cold water.

Sponsors

Johannes Gutenberg University Mainz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy volunteers with no cardiovascular risk factor, no current disease, normal laboratory parameters and ECG.

Exclusion criteria

* any active disease

Design outcomes

Primary

MeasureTime frameDescription
Change in FMD in response to sympathetic activationChange in FMD before versus 1 Minute after begin of interventionFlow-mediated dilation will be measured at rest and during each of the interventions.

Secondary

MeasureTime frameDescription
Change in FMC during sympathetic activationChange in FMC before versus 1 minute after begin of each interventionChange in Flow-mediated constriction induced by each of the interventions.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026